|
KCNQ1
|
|
|
Gene Symbol |
KCNQ1 |
|
Aliases |
ATFB1, ATFB3, JLNS1, KCNA8, KCNA9, KVLQT1, Kv1.9, Kv7.1, LQT, LQT1, RWS, SQT2, WRS |
|
Entrez Gene ID |
|
|
Gene Name |
Potassium voltage-gated channel subfamily Q member 1 |
|
Chromosomal Location |
11p15.5-p15.4 |
|
HGNC ID |
|
|
Summary |
This gene encodes a voltage-gated potassium channel required for repolarization phase of the cardiac action potential. This protein can form heteromultimers with two other potassium channel proteins, KCNE1 and KCNE3. Mutations in this gene are associated with hereditary long QT syndrome 1 (also known as Romano-Ward syndrome), Jervell and Lange-Nielsen syndrome, and familial atrial fibrillation. This gene exhibits tissue-specific imprinting, with preferential expression from the maternal allele in some tissues, and biallelic expression in others. This gene is located in a region of chromosome 11 amongst other imprinted genes that are associated with Beckwith-Wiedemann syndrome (BWS), and itself has been shown to be disrupted by chromosomal rearrangements in patients with BWS. Alternatively spliced transcript variants have been found for this gene. [provided by RefSeq, Aug 2011]
|
|
RefSeq DNA |
|
|
RefSeq mRNA |
|
|
e!Ensembl
|
Gene Ontology (GO)
GO ID |
Ontology |
Function |
Evidence |
Reference |
GO:0007605 |
Biological process |
Sensory perception of sound |
TAS |
9020846 |
GO:0008016 |
Biological process |
Regulation of heart contraction |
IC |
8900283 |
GO:0010460 |
Biological process |
Positive regulation of heart rate |
IMP |
19646991 |
GO:0035690 |
Biological process |
Cellular response to drug |
IDA |
9108097 |
GO:0060048 |
Biological process |
Cardiac muscle contraction |
IMP |
8528244 |
GO:0060306 |
Biological process |
Regulation of membrane repolarization |
IDA |
11299204 |
GO:0060306 |
Biological process |
Regulation of membrane repolarization |
IMP |
8900283 |
GO:0060307 |
Biological process |
Regulation of ventricular cardiac muscle cell membrane repolarization |
IMP |
8528244 |
GO:0060372 |
Biological process |
Regulation of atrial cardiac muscle cell membrane repolarization |
IMP |
12522251 |
GO:0060452 |
Biological process |
Positive regulation of cardiac muscle contraction |
IMP |
19646991 |
GO:0071320 |
Biological process |
Cellular response to cAMP |
IDA |
11299204, 16002409 |
GO:0071320 |
Biological process |
Cellular response to cAMP |
IMP |
18093912 |
GO:0071805 |
Biological process |
Potassium ion transmembrane transport |
IBA |
21873635 |
GO:0071805 |
Biological process |
Potassium ion transmembrane transport |
IDA |
9354802, 11299204, 16002409 |
GO:0071872 |
Biological process |
Cellular response to epinephrine stimulus |
TAS |
11799244 |
GO:0086005 |
Biological process |
Ventricular cardiac muscle cell action potential |
IMP |
8528244 |
GO:0086011 |
Biological process |
Membrane repolarization during action potential |
IDA |
8900283, 11299204, 19646991 |
GO:0086013 |
Biological process |
Membrane repolarization during cardiac muscle cell action potential |
IMP |
8528244 |
GO:0086013 |
Biological process |
Membrane repolarization during cardiac muscle cell action potential |
TAS |
11299204 |
GO:0086014 |
Biological process |
Atrial cardiac muscle cell action potential |
IMP |
12522251 |
GO:0086091 |
Biological process |
Regulation of heart rate by cardiac conduction |
IMP |
8528244 |
GO:0097623 |
Biological process |
Potassium ion export across plasma membrane |
IBA |
21873635 |
GO:0097623 |
Biological process |
Potassium ion export across plasma membrane |
IDA |
8900283, 10400998, 17289006 |
GO:0098914 |
Biological process |
Membrane repolarization during atrial cardiac muscle cell action potential |
IMP |
12522251, 25786344 |
GO:0098915 |
Biological process |
Membrane repolarization during ventricular cardiac muscle cell action potential |
IMP |
8528244 |
GO:1901381 |
Biological process |
Positive regulation of potassium ion transmembrane transport |
IDA |
8900283 |
GO:0005737 |
Cellular component |
Cytoplasm |
IDA |
25037568 |
GO:0005764 |
Cellular component |
Lysosome |
IDA |
21957902 |
GO:0005769 |
Cellular component |
Early endosome |
IDA |
21957902 |
GO:0005769 |
Cellular component |
Early endosome |
IMP |
23529131 |
GO:0005770 |
Cellular component |
Late endosome |
IDA |
21957902 |
GO:0005783 |
Cellular component |
Endoplasmic reticulum |
IDA |
21228319, 24855057 |
GO:0005783 |
Cellular component |
Endoplasmic reticulum |
IPI |
24855057 |
GO:0005886 |
Cellular component |
Plasma membrane |
IDA |
10646604, 21228319, 22024150, 23529131, 24184248, 25037568, 25705178 |
GO:0008076 |
Cellular component |
Voltage-gated potassium channel complex |
IBA |
21873635 |
GO:0008076 |
Cellular component |
Voltage-gated potassium channel complex |
IC |
8900283 |
GO:0008076 |
Cellular component |
Voltage-gated potassium channel complex |
IDA |
16002409, 17289006, 19646991 |
GO:0016021 |
Cellular component |
Integral component of membrane |
IBA |
21873635 |
GO:0016323 |
Cellular component |
Basolateral plasma membrane |
IDA |
21228319, 21957902 |
GO:0034702 |
Cellular component |
Ion channel complex |
IPI |
24855057 |
GO:0045121 |
Cellular component |
Membrane raft |
IDA |
20533308, 24855057 |
GO:0005249 |
Molecular function |
Voltage-gated potassium channel activity |
IBA |
21873635 |
GO:0005249 |
Molecular function |
Voltage-gated potassium channel activity |
IDA |
8900283, 17289006, 24855057 |
GO:0005249 |
Molecular function |
Voltage-gated potassium channel activity |
IDA |
16002409 |
GO:0005251 |
Molecular function |
Delayed rectifier potassium channel activity |
IBA |
21873635 |
GO:0005251 |
Molecular function |
Delayed rectifier potassium channel activity |
IDA |
12522251, 24184248, 24269949, 25037568 |
GO:0005251 |
Molecular function |
Delayed rectifier potassium channel activity |
IDA |
8900283, 9354802, 10400998, 11299204, 19646991 |
GO:0005515 |
Molecular function |
Protein binding |
IPI |
19521339, 19687231, 20533308, 22024150, 23529131 |
GO:0005516 |
Molecular function |
Calmodulin binding |
IBA |
21873635 |
GO:0005516 |
Molecular function |
Calmodulin binding |
IDA |
18165683 |
GO:0005546 |
Molecular function |
Phosphatidylinositol-4,5-bisphosphate binding |
IDA |
25037568 |
GO:0008157 |
Molecular function |
Protein phosphatase 1 binding |
IDA |
11799244 |
GO:0015271 |
Molecular function |
Outward rectifier potassium channel activity |
IBA |
21873635 |
GO:0015271 |
Molecular function |
Outward rectifier potassium channel activity |
IDA |
9312006, 11101505, 25705178 |
GO:0034236 |
Molecular function |
Protein kinase A catalytic subunit binding |
IDA |
11799244 |
GO:0034237 |
Molecular function |
Protein kinase A regulatory subunit binding |
IDA |
11799244 |
GO:0044325 |
Molecular function |
Ion channel binding |
IPI |
11101505, 12324418, 20196769, 24855057, 25037568 |
GO:0086008 |
Molecular function |
Voltage-gated potassium channel activity involved in cardiac muscle cell action potential repolarization |
IMP |
12522251 |
GO:0086089 |
Molecular function |
Voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization |
IBA |
21873635 |
GO:0086089 |
Molecular function |
Voltage-gated potassium channel activity involved in atrial cardiac muscle cell action potential repolarization |
IMP |
12522251, 25786344 |
GO:0097110 |
Molecular function |
Scaffold protein binding |
IPI |
11799244, 16002409, 18093912 |
GO:1902282 |
Molecular function |
Voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization |
IBA |
21873635 |
GO:1902282 |
Molecular function |
Voltage-gated potassium channel activity involved in ventricular cardiac muscle cell action potential repolarization |
IMP |
8528244 |
|
Protein Information |
|
Protein Name |
Potassium voltage-gated channel subfamily KQT member 1, IKs producing slow voltage-gated potassium channel subunit alpha KvLQT1, kidney and cardiac voltage dependend K+ channel, potassium channel, voltage gated KQT-like subfamily Q, member 1, potassium voltage-gated channel, KQT-like subfamily, member 1, slow delayed rectifier channel subunit, voltage-gated potassium channel subunit Kv7.1 |
|
Function |
Potassium channel that plays an important role in a number of tissues, including heart, inner ear, stomach and colon (By similarity) (PubMed:10646604). Associates with KCNE beta subunits that modulates current kinetics (By similarity) (PubMed:9312006, PubMed:9108097, PubMed:8900283, PubMed:10646604, PubMed:11101505, PubMed:19687231). Induces a voltage-dependent by rapidly activating and slowly deactivating potassium-selective outward current (By similarity) (PubMed:9312006, PubMed:9108097, PubMed:8900283, PubMed:10646604, PubMed:11101505). Promotes also a delayed voltage activated potassium current showing outward rectification characteristic (By similarity). During beta-adrenergic receptor stimulation participates in cardiac repolarization by associating with KCNE1 to form the I(Ks) cardiac potassium current that increases the amplitude and slows down the activation kinetics of outward potassium current I(Ks) (By similarity) (PubMed:9312006, PubMed:9108097, PubMed:8900283, PubMed:10646604, PubMed:11101505). Muscarinic agonist oxotremorine-M strongly suppresses KCNQ1/KCNE1 current (PubMed:10713961). When associated with KCNE3, forms the potassium channel that is important for cyclic AMP-stimulated intestinal secretion of chloride ions (PubMed:10646604). This interaction with KCNE3 is reduced by 17beta-estradiol, resulting in the reduction of currents (By similarity). During conditions of increased substrate load, maintains the driving force for proximal tubular and intestinal sodium ions absorption, gastric acid secretion, and cAMP-induced jejunal chloride ions secretion (By similarity). Allows the provision of potassium ions to the luminal membrane of the secretory canaliculus in the resting state as well as during stimulated acid secretion (By similarity). When associated with KCNE2, forms a heterooligomer complex leading to currents with an apparently instantaneous activation, a rapid deactivation process and a linear current-voltage relationship and decreases the amplitude of the outward current (PubMed:11101505). When associated with KCNE4, inhibits voltage-gated potassium channel activity (PubMed:19687231). When associated with KCNE5, this complex only conducts current upon strong and continued depolarization (PubMed:12324418). Also forms a heterotetramer with KCNQ5; has a voltage-gated potassium channel activity (PubMed:24855057). Binds with phosphatidylinositol 4,5-bisphosphate (PubMed:25037568). .; [Isoform 2]: Non-functional alone but modulatory when coexpressed with the full-length isoform 1. |
|
|
|
|
|
UniProt |
|
|
PDB |
|
|
|
|
|
|
| |
Associated Diseases
Disease group | Disease Name | References |
Cardiovascular Diseases |
Atrial Fibrillation |
|
Short Qt Syndrome |
|
Coronary heart disease |
|
Cardiomyopathy |
|
Congenital, Hereditary, and Neonatal Diseases and Abnormalities |
Long QT Syndrome |
15935335, 22095730, 20138589, 20421371, 17053194, 17482572, 11530100, 12205790, 15234419, 11351021, 15176425, 15746441, 20031635, 15214551, 9693036, 12820704, 20348026, 14756674, 17091796, 9781056, 19165230, 16253915, 8872472, 12653681, 19843919, 12877697, 17984373, 9312006, 1240233, 16246960, 14998624, 16922724, 25741868, 27041150, 16414944, 8528244, 10973849, 27485560, 18580685, 14678125, 10220144, 9570196, 23350853, 23891399, 12205113, 15358555, 20660394, 19716085, 8487283, 22613981, 9654228, 22949429, 8818942, 10511610, 9386136, 15840476, 23251633, 10024302, 16556866, 10560595, 15466642, 26346102, 12442276, 27041096, 12702160, 9799083, 23092362, 22429796, 24006450, 24291113, 25037568, 20044973, 19841300, 24357532, 9272155, 19490272, 24666684, 22456477, 17905336, 28492, 10482963, 24269949, 10728423, 11799244, 24184248, 18400097, 10409658, 9024139, 19540844, 9702906, 19808498, 25705178, 9302275, 10367071, 25139741, 9323054, 99273, 24912595, 23631430, 22539601, 14510661, 12051962, 24552659, 22309168, 24033266, 10704188, 23098067, 26546361, 10090886, 18441444 |
Short Qt Syndrome |
|
Beckwith-Wiedemann Syndrome |
|
Marfan Syndrome |
|
Endocrine System Diseases |
Diabetes Mellitus |
18711366, 20174558, 21799836, 20581827, 25102180, 18711367, 22961080, 28869590, 23945395, 24390345, 24509480, 22885922, 28254843, 24101674, 19401414, 26818947, 20818381, 22325160, 21647700, 21874001, 241 |
PCOS |
|
Musculoskeletal Diseases |
Gout |
|
Neoplasms |
Adenocarcinoma |
|
Cribriform Carcinoma |
|
Intestinal Cancer |
|
Carcinoma |
|
Psychiatric/Brain disorders |
Obstructive Sleep Apnea |
|
Reproductive disorders |
Preeclampsia |
|
|
References |
|
|
Ezzidi Intissar, Mtiraoui Nabil, Mohmmed Ali Mohammed Eltigani, Masoudi Aqeel Al, Abu Duhier Faisel |
Prince Fahd Bin Sultan Research Chair, Using Advance Technology for Diseases Detection and Treatment, Faculty of Applied Medical Sciences, University of Tabuk, Tabuk, Saudi Arabia. iezzidi@ut.edu.sa. |
J Genet. 2018 Dec;97(5):1213-1223. |
Abstract
Polycystic ovary syndrome (PCOS) is a common endocrine disorder in females, and is associated with altered metabolic processes in particular insulin resistance and diabetes mellitus. PCOS shares with type-2 diabetes (T2D) a number of features, including beta cell dysfunction, impaired glucose tolerance and dyslipidaemia. Recently, genomewide association studies (GWAS) have reported a number of genes with reproducible associations and susceptibilities to T2D. To address this, we examined the association between the T2D GWAS candidate genes (CDKAL1, CDKN2B, COL8A1, HHEX, IGF2BP2, KCNJ1, KCNQ1 and SLC30A8) and PCOS in Saudi women. A case-control study, includes 162 cases and 162 controls was enrolled. Genotyping was carried out by the allelicdiscrimination method. Our results showed that the variants including rs792837 of COL8A1, rs61873498 of KCNQ1 and rs13266634 of SLC30A8 genes to be significantly more frequent in PCOS patients than in controls. Our results suggest that COL8A1, KCNQ1 and SLC30A8, which are previously identified through GWAS as T2D-associated genes, are associated with PCOS. |
|
|
|
|